Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports
The pharmaceutical manufacturer Eli Lilly announced on Wednesday that its obesity drug tirzepatide, or Zepbound, provided considerable relief to overweight or obese people who had obstructive sleep apnea, or episodes…